Tech Company Financing Transactions
BrightInsight Funding Round
Eclipse, General Catalyst and Insight Venture Partners invested in a $13 million funding round for BrightInsight. The financing round was announced on 1/20/2026.
Transaction Overview
Company Name
Announced On
1/20/2026
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate development of its AI-enabled medication persistence and adherence solutions and enable programs, such as the Patient App from its collaboration with Sanofi and their partner, Regeneron, across a broad range of diseases and therapies globally.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
6201 America Center Dr.
San Jose, CA 95002
USA
San Jose, CA 95002
USA
Phone
Undisclosed
Website
Email Address
Overview
BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Our medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/19/2026: Noveon Magnetics venture capital transaction
Next: 1/20/2026: Ivo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








